|
A Double-Blind (Sponsor Unblinded), Randomized, Placebo-Controlled, Single and Repeated Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK3640254 in Healthy Participants |
GSK3640254 |
207187 |
NCT03231943 2017-001367-21 |
Infection, Human Immunodeficiency Virus |
Phase 1 |
|
|
|
|
This study is available in CDISC format. |
April 2021 |